Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Mayo Clinic
Boston University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)